Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Missense and frameshift mutations in
TRAF family member-associated NF-kappa-B activator
(
TANK
)-binding kinase 1 (TBK1) have been reported in European sporadic and familial
amyotrophic lateral sclerosis
(
ALS
) cohorts. To assess the role of TBK1 in
ALS
patient cohorts of wider ancestry, we have analyzed whole-exome sequence data from an Australian cohort of familial
ALS
(FALS) patients and controls. We identified a novel TBK1 deletion (c.1197delC) in a FALS patient of Chinese origin. This frameshift mutation (p.L399fs) likely results in a truncated protein that lacks functional domains required for adapter protein binding, as well as protein activation and structural integrity. No novel or reported TBK1 mutations were identified in FALS patients of European ancestry. This is the first report of a TBK1 mutation in an
ALS
patient of Asian origin and indicates that sequence variations in TBK1 are a rare cause of FALS in Australia.
...
PMID:Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin. 2635 Mar 99